Neurology

Spinal Muscular Atrophy

Expert Perspectives in Spinal Muscular Atrophy to Cover Key Topics in Spinal Muscular Atrophy Treatment

expert perspectives by John Brandsema, MD; Jenna Klotz, MD, MS; Julie A. Parsons, MD

Overview

Expert Perspectives® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives® in Spinal Muscular Atrophy will feature selected topics in Spinal Muscular Atrophy that we hope you will find of value in your clinical practice.

VIEW THE TOPICS

Expert Roundtables

Clinical progression of Spinal Muscular Atrophy
New drug development and treatment considerations in Spinal Muscular Atrophy
Treatment algorithm and best practices in the management of Spinal Muscular Atrophy

Clinical Topic Updates

Biomarkers for Spinal Muscular Atrophy
Combination therapy for patients with Spinal Muscular Atrophy
Respiratory complications associated with Spinal Muscular Atrophy

Patient Care Perspectives

Ethical issues associated with Spinal Muscular Atrophy patient care
Impaired motor functioning in Spinal Muscular Atrophy
The role of multidisciplinary care in Spinal Muscular Atrophy

Profile

John Brandsema, MD

Associate Professor of Clinical Neurology
Perelman School of Medicine at the University of Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, PA

Profile

Jenna Klotz, MD, MS

Clinical Associate Professor of Neurology and Neurological Sciences
Director, Pediatric Neuromuscular Neurodiagnostic Lab
Stanford University School of Medicine/Stanford Medicine Children’s Health
Palo Alto, CA

Profile

Julie A. Parsons, MD

Professor of Clinical Pediatrics and Neurology
Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders
Codirector, Neuromuscular Clinic
Children's Hospital Colorado
University of Colorado School of Medicine
Aurora, CO